Source

Commission Implementing Regulation (EU) 2023/1446 of 12 July 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,5-dichlorobenzoic acid methylester, acetic acid, aluminium ammonium sulphate, aluminium phosphide, aluminium silicate, calcium carbide, cymoxanil, dodemorph, ethylene, extract from tea tree, fat distillation residues, fatty acids C7-C20, flonicamid (IKI-220), gibberellic acid, gibberellins, halosulfuron-methyl, hydrolysed proteins, iron sulphate, magnesium phosphide, maltodextrin, metamitron, plant oils/clove oil, plant oils/rape seed oil, plant oils/spear mint oil, pyrethrins, sulcotrione, tebuconazole and urea (Text with EEA relevance)

Implementing Regulation (EU) 2023/1446 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: 1. Part A is amended as follows: (1) in the sixth column, expiration of approval, of row 218, Acetic acid, the date is replaced by ‘30 November 2026’; (2) in the sixth column, expiration of approval, of row 219, Aluminium ammonium sulphate, the date is replaced by ‘15 December 2024’; (3) in the sixth column, expiration of approval, of row 220, Aluminium silicate, the date is replaced by ‘15 December 2024’; (4) in the sixth column, expiration of approval, of row 223, Calcium carbide, the date is replaced by ‘30 November 2026’; (5) in the sixth column, expiration of approval, of row 227, Ethylene, the date is replaced by ‘30 November 2026’; (6) in the sixth column, expiration of approval, of row 228, Extract from tea tree, the date is replaced by ‘31 January 2026’; (7) in the sixth column, expiration of approval, of row 229, Fat distillation residues, the date is replaced by ‘15 December 2024’; (8) in the sixth column, expiration of approval, of row 230, Fatty acids C7 to C20, the date is replaced by ‘15 December 2024’; (9) in the sixth column, expiration of approval, of row 232, Gibberellic acid, the date is replaced by ‘15 July 2025’; (10) in the sixth column, expiration of approval, of row 233, Gibberellins, the date is replaced by ‘15 July 2025’; (11) in the sixth column, expiration of approval, of row 234, Hydrolysed proteins, the date is replaced by ‘15 April 2025’; (12) in the sixth column, expiration of approval, of row 235, Iron sulphate, the date is replaced by ‘30 November 2026’; (13) in the sixth column, expiration of approval, of row 241, Plant oils/clove oil, the date is replaced by ‘31 January 2026’; (14) in the sixth column, expiration of approval, of row 242, Plant oils/rape seed oil, the date is replaced by ‘15 December 2024’; (15) in the sixth column, expiration of approval, of row 243, Plant oils/spear mint oil, the date is replaced by ‘31 January 2026’; (16) in the sixth column, expiration of approval, of row 246, Pyrethrins, the date is replaced by ‘15 June 2026’; (17) in the sixth column, expiration of approval, of row 257, Urea, the date is replaced by ‘30 November 2026’; (18) in the sixth column, expiration of approval, of row 260, Aluminium phosphide, the date is replaced by ‘30 November 2026’; (19) in the sixth column, expiration of approval, of row 262, Magnesium phosphide, the date is replaced by ‘30 November 2026’; (20) in the sixth column, expiration of approval, of row 263, Cymoxanil, the date is replaced by ‘15 August 2026’; (21) in the sixth column, expiration of approval, of row 264, Dodemorph, the date is replaced by ‘30 November 2026’; (22) in the sixth column, expiration of approval, of row 265, 2,5-Dichlorobenzoic acid methylester, the date is replaced by ‘30 November 2026’; (23) in the sixth column, expiration of approval, of row 266, Metamitron, the date is replaced by ‘30 November 2026’; (24) in the sixth column, expiration of approval, of row 267, Sulcotrione, the date is replaced by ‘30 November 2026’; (25) in the sixth column, expiration of approval, of row 268, Tebuconazole, the date is replaced by ‘15 August 2026’; (26) in the sixth column, expiration of approval, of row 305, Flonicamid (IKI-220), the date is replaced by ‘30 November 2026’; 2. Part B is amended as follows: (1) in the sixth column, expiration of approval, of row 35, Halosulfuron-methyl, the date is replaced by ‘31 March 2025’; (2) in the sixth column, expiration of approval, of row 44, Maltodextrin, the date is replaced by ‘28 February 2026’.

Other acts of the same type

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview